{
  "id": 6429071,
  "title": "Ozempic and Wegovy linked to nearly 40% fewer asthma attacks",
  "url": "https://urgent.news/2026/09/09/ozempic-and-wegovy-linked-to-nearly-40-fewer-asthma-attacks-6429071",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-09-09T13:06:53.000Z",
  "source": {
    "name": "ScienceDaily Health",
    "slug": "sciencedaily-health",
    "url": "https://www.sciencedaily.com/releases/2026/09/260909005155.htm"
  },
  "original_language": "en",
  "account": null,
  "summary": "Semaglutide, the drug found in Ozempic and Wegovy, was linked to nearly 40% fewer asthma attacks in a large real-world study. It was also associated with about 20% fewer COPD flare-ups. Researchers say GLP-1 drugs may offer respiratory benefits in addition to their effects on diabetes and obesity, but clinical trials are needed to confirm the findings.",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}